Quality of life assessment and patient acceptability of intermittent versus continuous sex hormone suppression as treatment for locally advanced or metastatic prostatic cancer
| ISRCTN | ISRCTN51203558 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN51203558 |
| Secondary identifying numbers | N0080056792 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 17/09/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Timothy Philp
Scientific
Scientific
Consultant Urologist
WXUHT
London
E11 1NR
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | |
| Study objectives | This study will investigate patient acceptance, quality of life and survival/disease progression free interval in patients with locally advanced or metastatic prostate cancer in remission after six months treatment and disease control with androgen blockade. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cancer: Prostate |
| Intervention | Intermittent vs continuous sex hormone suppression |
| Intervention type | Other |
| Primary outcome measure | Patient acceptance, quality of life and survival/disease progression. |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 31/12/1997 |
| Completion date | 31/12/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Male |
| Target number of participants | 200 |
| Key inclusion criteria | 200 patients recruited from Urological Oncology Clinical who have had six months androgen blockade. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 31/12/1997 |
| Date of final enrolment | 31/12/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Consultant Urologist
London
E11 1NR
United Kingdom
E11 1NR
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Phone | +44 (0)20 7307 2622 |
|---|---|
| dhmail@doh.gsi.org.uk | |
| Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Charity
Orchid Cancer Appeal (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/10/2004 | Yes | No |
